ArticleThoracic cancer2017

Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.

Jianchun Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.